PERRIGO COMPANY PLC
PRGOStock
$11.16−62.48%52W
Market Cap$1.52B
P/E—
Div yield11.43%
Beta0.53
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-39.89%
Price vs S&P 500 (4W)-5.47%
VGM Score48.73
Market Capitalization$1.52B
Indicated Dividend Yield (Annual)11.43%
Earnings Surprise History
Q1 260.43est. 0.32
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
3.80
3.80
3.80
3.80
Industry Peers — Pharmaceuticals(563)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
PRGOPERRIGO COMPANY PLC | A | D | D | $11.16 |
| LLYEli Lilly & Co. | D | B | B | $1169.17 |
| JNJJohnson & Johnson | D | C | B | $249.97 |
| ABBVABBVIE INC. | D | C | B | $254.39 |
| MRKMerck & Co., Inc. | C | C | B | $127.63 |
| NVSNovartis AG | C | C | C | $152.73 |
| NVONovo-Nordisk A/S | C | B | C | $51.48 |
| AZNAstraZeneca PLC | C | B | C | $169.29 |
| ABTAbbott Laboratories | C | C | D | $98.83 |
| PFEPfizer Inc. | B | C | C | $25.14 |
| VRTXVertex Pharmaceuticals Inc | D | C | C | $486.03 |
About
Perrigo is a global consumer health company specializing in self-care products. Its North American business, representing approximately two-thirds of sales, operates as a major private-label supplier to retailers including Walmart, Amazon, Costco, and CVS. Internationally, it markets branded products—including Compeed, Solpadeine, Coldrex, and ellaOne—in Europe, Australia, and select Asian markets. The dual strategy balances high-volume private-label revenue with branded product margins.